NEI
BIIB icon

Northwest & Ethical Investments’s Biogen BIIB Stock Holding History

Northwest & Ethical Investments’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$582K Buy
2,693
+693
+35% +$133K 0.01% 322
2026
Q1 		$367K Hold
2,000
– – 0.01% 425
2025
Q4 		$352K Hold
2,000
– – 0.01% 430
2025
Q3 		$280K Hold
2,000
– – 0.01% 451
2025
Q2 		$251K Hold
2,000
– – 0.01% 444
2025
Q1 		$274K Hold
2,000
– – 0.01% 432
2024
Q4 		$306K Sell
2,000
-5,428
-73% -$916K 0.01% 372
2024
Q3 		$1.44M Sell
7,428
-1,139
-13% -$238K 0.04% 277
2024
Q2 		$1.99M Hold
8,567
– – 0.06% 248
2024
Q1 		$1.85M Buy
8,567
+6,567
+328% +$1.54M 0.05% 253
2023
Q4 		$518K Buy
+2,000
New +$491K 0.02% 311
2020
Q3 		– Sell
-5,109
Closed -$1.37M – 401
2020
Q2 		$1.37M Sell
5,109
-1,530
-23% -$460K 0.06% 278
2020
Q1 		$2.1M Sell
6,639
-100
-1% -$30.3K 0.12% 203
2019
Q4 		$2M Sell
6,739
-5,525
-45% -$1.53M 0.09% 268
2019
Q3 		$2.86M Sell
12,264
-4,166
-25% -$970K 0.14% 196
2019
Q2 		$3.84M Sell
16,430
-170
-1% -$39.3K 0.19% 154
2019
Q1 		$3.92M Sell
16,600
-7,764
-32% -$2.44M 0.2% 153
2018
Q4 		$7.33M Buy
24,364
+9,152
+60% +$2.92M 0.43% 59
2018
Q3 		$5.37M Buy
+15,212
New +$5.24M 0.34% 88
2018
Q2 		– Sell
-300
Closed -$82.1K – 361
2018
Q1 		$82.1K Hold
300
– – 0.01% 346
2017
Q4 		$95.6K Sell
300
-3,500
-92% -$1.12M 0.01% 338
2017
Q3 		$1.19M Buy
3,800
+3,563
+1,503% +$1.06M 0.07% 272
2017
Q2 		$91.4K Hold
237
– – 0.01% 350
2017
Q1 		$64.8K Buy
237
+100
+73% +$28.3K ﹤0.01% 373
2016
Q4 		$38.9K Buy
+137
New +$40.6K ﹤0.01% 377
2015
Q3 		– Sell
-8,500
Closed -$3.43M – 206
2015
Q2 		$3.43M Buy
+8,500
New +$3.41M 0.23% 121

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northwest & Ethical Investments's BIIB Position: Q2 2026 in Review

Northwest & Ethical Investments increased its Biogen (BIIB) stake by 35% in Q2 2026, buying an estimated $133K and bringing the position to 2,693 shares worth $582K. The position accounts for 0.01% of the portfolio, ranked #322.

Northwest & Ethical Investments first reported a position in BIIB in Q2 2015 and has held it in 26 quarters since. The position peaked at $7.33M in Q4 2018. 1,038 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Northwest & Ethical Investments held 2,693 shares of Biogen worth $582K as of Q2 2026.
  • Northwest & Ethical Investments bought 693 Biogen shares in Q2 2026, an estimated $133K.
  • Biogen made up 0.01% of Northwest & Ethical Investments's portfolio in Q2 2026, its #322 holding.
  • Northwest & Ethical Investments first reported a position in Biogen in Q2 2015 and has held it in 26 quarters since.
  • Northwest & Ethical Investments's Biogen position peaked at $7.33M in Q4 2018.
  • 1,038 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Northwest & Ethical Investments's 13F filing for Q2 2026, filed 13 Aug 2026.